Carl Icahn has called off the dogs hounding DNA-sequencing company Illumina

Carl Icahn has decided not to launch a fresh proxy fight at DNA sequencing company Illumina Inc. this year, a person familiar with the matter said. The activist investor didn’t nominate directors for seats on the board of Illumina before a deadline to do so passed, the person said, asking not to be identified discussing […]

Posted from: this blog via Microsoft Power Automate.